To include your compound in the COVID-19 Resource Center, submit it here.
Biogen Inc. (NASDAQ:BIIB), Cambridge, Mass. Merck & Co. Inc. (NYSE:MRK), Kenilworth, N.J. Samsung Group, Seoul, South Korea Product: Biosimilar insulin glargine
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury